Navigation Links
Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results
Date:3/10/2011

antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases.  For more information, please visit http://www.insmed.com.

Forward-Looking Statements This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to our financial position, results of operations, the development of our products, and business strategies, plans and objectives of management, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements.  Our results may also be affected by such factors as the receipt and timing of FDA and other regulatory approvals, if at all, competitive developments affecting our product development, delays in product development or clinical trials, and patent disputes involving currently developing products.  The risks and uncertainties include, without limitation, we may be unsuccessful in developing our product candidates or receiving necessary regulatory approvals, our product candidates may not prove to be commercially successful, our expenses may be higher than anticipated and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2009.  Investors are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release.  We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated e
'/>"/>

SOURCE Insmed Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Insmed to Host Second Quarter 2009 Conference Call
2. Insmed Announces Addition to the Russell 3000(R) Index
3. Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy
4. Insmed CEO Resigns Due to Health Concerns
5. Insmed Announces First Quarter 2009 Financial Results
6. Insmed Regains NASDAQ Compliance
7. Insmed to Host First Quarter 2009 Conference Call
8. Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)
9. Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
10. Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results
11. Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... /CNW/ - A new and innovative service has won ... North America,s largest packaging trade association. ... the "Sustainability, service" category of the PAC Global ... is a service that scores clients, packaging against ... This benchmarking process shows clients how their packaging ...
(Date:4/23/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... quarter 2015 results before the Nasdaq market opens on ... conference call and webcast to discuss its financial results ... 2015 at 8:00 a.m. Eastern Time (5:00 a.m. Pacific ... call by dialing 866-952-1906 (US) or 785-424-1825 (International) using ...
(Date:4/23/2015)... April 23, 2015  Cryoport, Inc. (OTCBB: CYRX) ... solutions for the life sciences industry, today announced ... logistics solutions within the animal husbandry market by ... to support the shipment of equine semen for ... horse Stallions. Animal husbandry is a ...
(Date:4/23/2015)... Glemser Technologies is ... Enterprise Content Division (ECD) Certified Solution Partner to ... for Life Sciences Solution Suite . The accreditation ... to provide life sciences companies of all sizes ... EMC Documentum Solution Suite offers four modules: Quality ...
Breaking Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results 2Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms 2Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms 3Glemser Earns Accreditation for Life Sciences Solution Suite 2
... 25 NanoBio(R) Corporation, a,biopharmaceutical company developing novel ... serious infections, today announced,the addition of four new ... Ma, PharmD, Ph.D.; Susan Ciotti, Ph.D.; Robert L. ... in developing and commercializing,its novel topical anti-infectives and ...
... Cell biologist receives $500,000 ,genius award, with ,no ... Roth, Ph.D., a cell biologist at,Fred Hutchinson Cancer ... MacArthur Fellowships, a "genius" award given annually by ... will receive $500,000 over,five years of "no-strings-attached" support. ...
... ST. LOUIS and REHOVOT, Israel, Sept. 25 ,Monsanto ... (TASE: EVGN) today announced,a collaboration to improve nitrogen ... the agreement, Monsanto gains exclusive rights to,a number ... maintain yield,with lower applications of nitrogen. Monsanto will ...
Cached Biology Technology:NanoBio Expands Drug Development Team for Its Anti-Infective Products 2NanoBio Expands Drug Development Team for Its Anti-Infective Products 3Basic Scientist Mark Roth Wins MacArthur Fellowship 2Basic Scientist Mark Roth Wins MacArthur Fellowship 3Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research 2Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research 3
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial ... Valley to implant a new miniaturized, wireless monitoring sensor ... is the first and only FDA-approved heart failure monitoring ... admissions when used by physicians to manage heart failure. ... that is implanted in the pulmonary artery (PA) during ...
(Date:4/14/2015)... OXFORD, Conn. , April 14, 2015 ... "Company"), a biometric authentication company focused on the growing ... has been nominated for the 2015 New York Design ... The Design100, New York City Design Awards are ... are based on over 2,500 ratings from the marketplace, ...
(Date:4/9/2015)... Calif. , April 9, 2015 Synaptics ... interface solutions, announced today that it will report financial ... Thursday, April 23, 2015, after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2
... the Bronx Zoo-based Wildlife Conservation Society (WCS) warn that ... Asia and beyond must focus on better management practices ... working with Mongolian agencies on the ground in Mongolia's ... recently contracted the virus. , "We're working with our ...
... modest suppression of growth hormone and related compounds beginning ... of several types of cancer, researchers from Wake Forest ... at ENDO 2005, the annual meeting of the Endocrine ... and insulin-like growth factor (IGF-1) also may decrease cancer ...
... researchers have discovered an inherited structural mechanism that ... some patients. The mechanism decreases a protein and ... drugs differently. Thiopurine therapies are used to treat ... transplants. The Mayo researchers say their finding advances ...
Cached Biology News:WCS says avian flu prevention should focus on farms, markets 2Suppressing growth hormone in early adulthood may prevent cancer 2Genomics researchers discover protein deficit that causes drug toxicity 2